Top Clinical Trials companies in Canada by Price to Earnings Ratio (P/E)

This ranking features the top 6 Clinical Trials companies in Canada ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of -2.76, for January 15, 2025.

Canada

Clinical Trials

#	Name	Price to Earnings Ratio (P/E)	Reported Date	Stock Price	Change	Country
1	InMed Pharmaceuticals Inc. 1 INM	-0.00	Jan. 14, 2025	USD 4.08	-3.32%	Canada
2	XORTX Therapeutics Inc. 2 XRTX.V	-1.41	Jan. 14, 2025	USD 1.25	-0.34%	Canada
3	ESSA Pharma Inc. 3 EPIX	-2.75	Jan. 14, 2025	USD 1.77	2.31%	Canada
4	Medicenna Therapeutics Corp. 4 MDNA.TO	-3.76	Jan. 14, 2025	USD 0.91	-2.78%	Canada
5	Eupraxia Pharmaceuticals Inc. 5 EPRX.TO	-3.82	Jan. 14, 2025	USD 3.02	1.15%	Canada
6	Cardiol Therapeutics Inc. 6 CRDL.TO	-4.79	Jan. 14, 2025	USD 1.25	-1.98%	Canada

Frequently Asked Questions

Which Clinical Trials company in Canada has the highest Price to Earnings Ratio (P/E) ?

The Clinical Trials company in Canada with the highest Price to Earnings Ratio (P/E) is InMed Pharmaceuticals Inc. (NasdaqCM: INM) at -0.00.
Which Clinical Trials company in Canada has the lowest Price to Earnings Ratio (P/E) ?

The Clinical Trials company in Canada with the lowest Price to Earnings Ratio (P/E) is Cardiol Therapeutics Inc. (Toronto Stock Exchange: CRDL.TO) at -4.79.

What are the top 10 Clinical Trials companies in Canada by Price to Earnings Ratio (P/E) ?

The top 10 Clinical Trials companies in Canada by Price to Earnings Ratio (P/E) are InMed Pharmaceuticals Inc., XORTX Therapeutics Inc., ESSA Pharma Inc., Medicenna Therapeutics Corp., Eupraxia Pharmaceuticals Inc. and Cardiol Therapeutics Inc..
What are the bottom 10 Clinical Trials companies in Canada by Price to Earnings Ratio (P/E) ?

The bottom 10 Clinical Trials companies in Canada by Price to Earnings Ratio (P/E) are Cardiol Therapeutics Inc., Eupraxia Pharmaceuticals Inc., Medicenna Therapeutics Corp., ESSA Pharma Inc., XORTX Therapeutics Inc. and InMed Pharmaceuticals Inc..